424 Capital Exits Healthcare Tech Firm Reverba in PE Deal
Boston-area private equity firm 424 Capital has completed its exit from Reverba, a tech-enabled services company in its healthcare portfolio.
424 Capital, a Wakefield, Massachusetts-based lower middle market private equity firm, announced Wednesday it has successfully exited its investment in Reverba, marking a completed transaction for the firm's healthcare and energy transition-focused portfolio.
The firm describes itself as specializing in tech-enabled services companies operating within the healthcare and energy transition sectors, targeting businesses in the lower middle market segment of the private equity landscape.
Read more Leverage Shares Launches 2x Long Anthropic ETF as ANT Debuts on Nasdaq →
No financial terms of the exit were disclosed in the announcement. The transaction represents the conclusion of 424 Capital's investment cycle in Reverba, though the buyer and specific deal metrics were not made public at the time of release.
The exit underscores ongoing consolidation activity within the lower middle market, where private equity sponsors have continued to pursue and divest tech-enabled services platforms despite broader uncertainty in deal financing conditions. Healthcare-focused PE exits have remained active as strategic and financial buyers compete for established service businesses with recurring revenue characteristics.
Continue reading at All Financial Services & Investing.